Key Highlights Blue Wolf Capital acquires seven European facilities from Recipharm, specializing in oral solid, semi-solid, and liquid dosage pharmaceutical products.…
Key Highlights Julie O’Shaughnessy appointed as Chief Operating Officer of Vivodyne, overseeing business operations and strategic growth. Brings extensive leadership…
Key Highlights Elliot Menschik, M.D., Ph.D., appointed as Chief Technology Officer and Board Director at Vivodyne. Brings extensive background as a serial…